Obstructive Sleep Apnea-OSA

Obstructive Sleep Apnea as a Potential Risk Factor for COVID-19: Expert Interview

By

Tori Rodriguez, MA, LPC, AHC

Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.

The Relationship Between OSA and Mood Disorders, Cognitive Impairment

By

Tori Rodriguez, MA, LPC, AHC

Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.

Cardiovascular Risk in Pediatric Obstructive Sleep Apnea: What Do We Know?

By

Tori Rodriguez, MA, LPC, AHC

A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.

CPAP Therapy Did Not Reduce Atrial Fibrillation Burden in Obstructive Sleep Apnea

By

Pulmonology Advisor Contributing Writer

Continuous positive airway pressure (CPAP) therapy did not reduce the burden of atrial fibrillation (AF) in patients with paroxysmal AF and sleep apnea.

Dysphagia Prevalence, Characteristics Among Patients With Obstructive Sleep Apnea

By

Sheila Jacobs

Approximately one-sixth of patients with obstructive sleep apnea (OSA) have demonstrated symptoms of dysphagia.

Pulse Rate Variability May Predict Stroke in Obstructive Sleep Apnea

By

Bryant Moeller

Pulse rate variability as detected by pulse oximetry could serve as a useful biomarker for stroke risk stratification in patients with obstructive sleep apnea.

Increased BMI in Patients With Obstructive Sleep Apnea After CPAP Treatment

By

Sheila Jacobs

In patients with obstructive sleep apnea, BMI values increased significantly following CPAP therapy.

Obstructive Sleep Apnea Associated With Specific Indicators of Aging

By

Kerry Leupold, DO

Obstructive sleep apnea in young patients results in pathophysiologic changes associated with aging.